J G Webb

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. ncbi Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis
    John G Webb
    Division of Cardiology, St Paul s Hospital and the Centre for Health Evaluation and Outcome Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Circulation 116:755-63. 2007
  2. doi Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes
    John G Webb
    St Paul s Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    Circulation 119:3009-16. 2009
  3. ncbi Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 63:89-93. 2004
  4. ncbi A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect
    John G Webb
    Division of Cardiology, Pharmacy Department, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 148:422-9. 2004
  5. ncbi Proximal protection during saphenous vein graft angioplasty: the Kerberos embolic protection system
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Catheter Cardiovasc Interv 64:383-6. 2005
  6. ncbi Percutaneous closure of an aortic prosthetic paravalvular leak with an Amplatzer duct occluder
    John G Webb
    Department of Cardiology, St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
    Catheter Cardiovasc Interv 65:69-72. 2005
  7. ncbi Percutaneous suture edge-to-edge repair of the mitral valve
    John G Webb
    St Paul s Hospital, University of British Columbia, Vancouver, Canada
    EuroIntervention 5:86-9. 2009
  8. ncbi Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus
    John G Webb
    St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Circulation 113:851-5. 2006
  9. ncbi Percutaneous aortic valve implantation retrograde from the femoral artery
    John G Webb
    Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
    Circulation 113:842-50. 2006
  10. doi Percutaneous aortic valve replacement will become a common treatment for aortic valve disease
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    JACC Cardiovasc Interv 1:122-6. 2008

Collaborators

Detail Information

Publications86

  1. ncbi Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis
    John G Webb
    Division of Cardiology, St Paul s Hospital and the Centre for Health Evaluation and Outcome Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Circulation 116:755-63. 2007
    ..Percutaneous aortic valve replacement represents an endovascular alternative to conventional open heart surgery without the need for sternotomy, aortotomy, or cardiopulmonary bypass...
  2. doi Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes
    John G Webb
    St Paul s Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    Circulation 119:3009-16. 2009
    ..Transcatheter aortic valve implantation is an alternative to open heart surgery in patients with aortic stenosis. However, long-term data on a programmatic approach to aortic valve implantation remain sparse...
  3. ncbi Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 63:89-93. 2004
    ..Further evolution of this technology will involve lower-profile devices with design features that facilitate vascular delivery, visualization, positioning, deployment, and valvular function...
  4. ncbi A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect
    John G Webb
    Division of Cardiology, Pharmacy Department, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 148:422-9. 2004
    ..The objective of this study was to evaluate, in a blinded, randomized, placebo-controlled fashion, whether intravenous NAC reduced CIN in the setting of cardiac catheterization in patients with preexisting renal insufficiency...
  5. ncbi Proximal protection during saphenous vein graft angioplasty: the Kerberos embolic protection system
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Catheter Cardiovasc Interv 64:383-6. 2005
    ..Although such systems are often effective, distal protection does have limitations. We report a novel proximal embolic protection and rinsing system intended to overcome some of these limitations...
  6. ncbi Percutaneous closure of an aortic prosthetic paravalvular leak with an Amplatzer duct occluder
    John G Webb
    Department of Cardiology, St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
    Catheter Cardiovasc Interv 65:69-72. 2005
    ..We describe in a patient with severe aortic prosthetic paravalvular leak the use of an Amplatzer duct occluder device resulting in effective closure and symptomatic improvement...
  7. ncbi Percutaneous suture edge-to-edge repair of the mitral valve
    John G Webb
    St Paul s Hospital, University of British Columbia, Vancouver, Canada
    EuroIntervention 5:86-9. 2009
    ....
  8. ncbi Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus
    John G Webb
    St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Circulation 113:851-5. 2006
    ..We evaluated the safety and feasibility of a transvenous catheter-delivered implantable device to provide a percutaneous alternative to surgical mitral annuloplasty...
  9. ncbi Percutaneous aortic valve implantation retrograde from the femoral artery
    John G Webb
    Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
    Circulation 113:842-50. 2006
    ..Retrograde prosthetic aortic valve implantation via the femoral artery has potential advantages. Percutaneous prosthetic aortic valve implantation via the femoral arterial approach is described and the initial experience reported...
  10. doi Percutaneous aortic valve replacement will become a common treatment for aortic valve disease
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    JACC Cardiovasc Interv 1:122-6. 2008
    ..Caution is prudent, however, in the future a more mature procedure might represent a viable alternative for a much broader range of patients...
  11. doi A new transcatheter aortic valve and percutaneous valve delivery system
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 53:1855-8. 2009
    ..We describe procedural and clinical outcomes in a high-risk cohort undergoing transcatheter aortic valve replacement with early next-generation transcatheter valve and delivery systems...
  12. doi Percutaneous transarterial aortic valve implantation: what do we know?
    John Webb
    St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC, Canada
    Eur Heart J 32:140-7. 2011
    ..Nevertheless considerable work needs to be done before the indications for TAVI are expanded into lower risk groups. We review what is currently known about percutaneous transarterial implantation of the aortic valve...
  13. ncbi Rapid pacing to facilitate transcatheter prosthetic heart valve implantation
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
    Catheter Cardiovasc Interv 68:199-204. 2006
    ..We describe the technique of, and our experience with, rapid ventricular burst pacing to facilitate transcatheter heart valve implantation...
  14. ncbi Percutaneous aortic valve replacement
    John G Webb
    St Paul s Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
    Curr Cardiol Rep 10:104-9. 2008
    ..Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality are competitive in comparison to conventional surgery in selected high-risk patients...
  15. doi Transcatheter percutaneous and transapical aortic valve replacement
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, USA
    Semin Thorac Cardiovasc Surg 19:304-10. 2007
    ..Uncertainty remains about outcomes, implications, durability, and the appropriate role for this new therapy. It appears likely that transcatheter valve implantation will become a more widely available and accepted therapeutic option...
  16. ncbi Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial
    John G Webb
    St Paul s Hospital, Vancouver, Canada
    J Am Coll Cardiol 42:1380-6. 2003
    ..We examined the clinical, angiographic, and procedural characteristics determining survival after percutaneous coronary intervention (PCI) for cardiogenic shock...
  17. ncbi Incidence, correlates, and outcome of cardiac arrest associated with percutaneous coronary intervention
    John G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver Canada
    Am J Cardiol 90:1252-4. 2002
  18. ncbi Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry
    J G Webb
    St Paul s Hospital, Vancouver, British Columbia, Canada
    Am Heart J 141:964-70. 2001
    ..The SHOCK Registry prospectively enrolled patients with cardiogenic shock complicating acute myocardial infarction in 36 multinational centers...
  19. ncbi Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    J G Webb
    St Paul s Hospital, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 36:1084-90. 2000
    ..We sought to examine the implications of the timing of onset of cardiogenic shock (CS) after acute myocardial infarction (MI)...
  20. ncbi Transient obstruction of the mitral valve by a massive thrombus complicating percutaneous valvuloplasty
    A W Chan
    Interventional Cardiology, St PaulOs Hospital, 502Eth 1160 Burrard Street, Vancouver, British Columbia, V6Z 2E8, Canada
    J Invasive Cardiol 12:324-6. 2000
    ..Circulatory arrest ensued. The thrombus was disrupted during cardiopulmonary resuscitation. Thrombolysis was administered and the patient recovered uneventfully...
  21. ncbi Facilitation of stent retention and retrieval with an emboli containment device
    J G Webb
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Catheter Cardiovasc Interv 50:215-7. 2000
    ..We describe how, when used for the prevention of distal embolization of atheromatous or thrombotic particles, this device may facilitate retention and retrieval of undeployed stents...
  22. ncbi Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?
    C R Thompson
    Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 36:1104-9. 2000
    ..Our objective was to define the outcomes of patients with cardiogenic shock (CS) due to severe mitral regurgitation (MR) complicating acute myocardial infarction (AMI)...
  23. ncbi Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
    V Menon
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, New York, New York 10025, USA
    J Am Coll Cardiol 36:1110-6. 2000
    ..We wished to assess the profile and outcomes of patients with ventricular septal rupture (VSR) in the setting of cardiogenic shock (CS) complicating acute myocardial infarction (MI)...
  24. doi Technical considerations to avoid pitfalls during transapical aortic valve implantation
    Daniel R Wong
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Thorac Cardiovasc Surg 140:196-202. 2010
    ..Transapical aortic valve implantation is a recent therapeutic advance for aortic valvular disease. We sought to identify complications--and the relevant technical and management considerations--from our learning curve with this procedure...
  25. ncbi The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
    V Menon
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, New York, New York 10025, USA
    J Am Coll Cardiol 36:1071-6. 2000
    ..We sought to evaluate the frequency of pulmonary congestion and associated clinical and hemodynamic findings in patients with suspected cardiogenic shock (CS)...
  26. doi Prevention and management of transcatheter balloon-expandable aortic valve malposition
    Abdullah M Al Ali
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Catheter Cardiovasc Interv 72:573-8. 2008
    ..To this end, we examined our experience during the developmental phases of transcatheter AVR and describe the causes and management of prosthetic valve malposition...
  27. doi Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications
    Jean Bernard Masson
    Division of Cardiology and Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    JACC Cardiovasc Interv 2:811-20. 2009
    ..Ultimately, improved understanding of the potential complications associated with TAVI might help improve outcomes and allow wider application of this therapy...
  28. ncbi Interventional management of cardiogenic shock
    J G Webb
    St Paul s Hospital, University of British Columbia, Vancouver
    Can J Cardiol 14:233-44. 1998
    ..Angiography can be performed at relatively low risk in shock patients. A window of opportunity is often available where revascularization may be of benefit...
  29. ncbi Retrieval and analysis of particulate debris after saphenous vein graft intervention
    J G Webb
    St Paul s Hospital, University of British Columbia, Vancouver, Canada
    J Am Coll Cardiol 34:468-75. 1999
    ..This study was designed to evaluate the composition and quantity of particulate debris resulting from vein graft intervention...
  30. doi Role of multislice computed tomography in transcatheter aortic valve replacement
    David A Wood
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Am J Cardiol 103:1295-301. 2009
    ..Neither eccentricity nor calcific deposits appeared to contribute significantly to severity of paravalvular regurgitation after TAVR...
  31. doi Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve
    Robert H Boone
    St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Catheter Cardiovasc Interv 75:286-94. 2010
    ..Transcatheter pulmonary valve implantation improves conduit hemodynamics through a minimally invasive approach. We present data for 7 patients treated with the Edwards SAPIEN transcatheter heart valve (THV)...
  32. doi Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation
    Jean Bernard Masson
    St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 76:165-73. 2010
    ..Implications of CAD and preprocedural revascularization in the setting of transcatheter aortic valve implantation (TAVI) are not known...
  33. ncbi Correlation of remote ST segment depression and coronary anatomy during acute coronary occlusion
    A W Chan
    Division of Cardiology, St Paul s Hospital, Vancouver, Canada
    Can J Cardiol 17:282-90. 2001
    ..The appearance of remote ST segment depression (RSTD) on an electrocardiogram (ECG) is associated with more extensive infarction and a worse clinical outcome than when RSTD is absent...
  34. doi Percutaneous mitral annuloplasty
    Jean Bernard Masson
    St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Coron Artery Dis 20:183-8. 2009
    ..We review current experimental percutaneous approaches to mitral annuloplasty...
  35. doi Transcatheter closure of paravalvular defects using a purpose-specific occluder
    Fabian Nietlispach
    St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    JACC Cardiovasc Interv 3:759-65. 2010
    ..This study sought to describe a method of paravalvular leak closure using a purpose-specific occlusion device...
  36. doi Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves
    John G Webb
    St Paul s Hospital, 1081 Burrard St, Vancouver, BC, Canada
    Circulation 121:1848-57. 2010
    ..Transcatheter heart valve implantation within a failed bioprosthesis, a "valve-in-valve" procedure, may offer a less invasive alternative...
  37. ncbi Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge
    R G Carere
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver
    Am Heart J 139:52-8. 2000
    ..The purpose of this study was to determine whether immediate suture closure of 8F femoral arterial puncture sites can facilitate same-day discharge after coronary angioplasty...
  38. ncbi Unprotected left main coronary artery stenting for cardiac allograft vasculopathy
    A W Chan
    Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada
    J Heart Lung Transplant 20:776-80. 2001
    ..We present our initial experience with stenting of the left main coronary artery in the setting of allograft vasculopathy...
  39. doi Atrioventricular block after transcatheter balloon expandable aortic valve implantation
    Ajay Sinhal
    Heart Centre, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    JACC Cardiovasc Interv 1:305-9. 2008
    ..Transcatheter aortic valve replacement (AVR) is a promising approach to aortic valve disease. The implications of this new therapy are not entirely known. We describe the potential for the development of new atrioventricular (AV) block...
  40. doi Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial
    Anthony Y Fung
    Vancouver General Hospital, British Columbia, Canada
    J Am Coll Cardiol 53:837-45. 2009
    ..The purpose of this study was to assess whether the early discontinuation of eptifibatide infusion in nonemergent percutaneous coronary intervention (PCI) is associated with a higher frequency of periprocedural ischemic myonecrosis...
  41. doi Current balloon-expandable transcatheter heart valve and delivery systems
    Fabian Nietlispach
    Department of Cardiology, St Paul s Hospital, British Columbia, Canada
    Catheter Cardiovasc Interv 75:295-300. 2010
    ..Transcatheter valve and valve delivery systems are undergoing rapid evolution. We describe the current generation balloon-expandable valve and delivery systems...
  42. doi Percutaneous coronary intervention and 30-day mortality: the British Columbia PCI risk score
    Jaap N Hamburger
    Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 74:377-85. 2009
    ..To construct a calculator to assess the risk of 30-day mortality following PCI...
  43. ncbi Transapical transcatheter aortic valve implantation in humans: initial clinical experience
    Samuel V Lichtenstein
    Divisions of Cardiology and Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Circulation 114:591-6. 2006
    ..We describe our experience with a new, minimally invasive, catheter-based approach to aortic valve implantation via left ventricular apical puncture without cardiopulmonary bypass or sternotomy...
  44. pmc Percutaneous aortic valve implantation: a case report
    Mann Chandavimol
    St Paul s Hospital, Vancouver, Canada
    Can J Cardiol 22:1159-61. 2006
    ..Currently, this procedure is an option only for symptomatic patients who are not appropriate candidates for surgical valve replacement...
  45. doi CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement
    Fabian Nietlispach
    Division of Interventional Cardiology, Department of Cardiology, St Paul s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada
    Swiss Med Wkly 139:458-62. 2009
    ..However, MSCT involves an additional contrast dye burden in patients often suffering from renal failure. In this study, the feasibility of direct-aortic-contrast-injection for MSCT was investigated, aiming to reduce total contrast load...
  46. doi Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort
    R Gurvitch
    St Paul s Hospital, 1081 Burrard St, Vancouver, British Columbia, Canada V6Z 1Y6
    Circulation 122:1319-27. 2010
    ..Although short- and medium-term outcomes after transcatheter aortic valve implantation are encouraging, long-term data on valve function and clinical outcomes are limited...
  47. doi Transapical transcatheter aortic valve implantation: follow-up to 3 years
    Jian Ye
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Thorac Cardiovasc Surg 139:1107-13, 1113.e1. 2010
    ..We now report clinical and echocardiographic outcomes of transapical aortic valve implantation in 71 patients...
  48. doi Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients
    Jian Ye
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Thorac Cardiovasc Surg 137:167-73. 2009
    ..This is, to date, the longest follow-up of patients undergoing transapical aortic valve implantation...
  49. doi Transapical transcatheter mitral valve-in-valve implantation in a human
    Anson Cheung
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Ann Thorac Surg 87:e18-20. 2009
    ..The transcatheter valve functioned properly postoperatively; however, the patient died of multiple organ dysfunction...
  50. doi The evolving role of MDCT in transcatheter aortic valve replacement: a radiologists' perspective
    Jonathon Leipsic
    Department of Radiology, St Paul s Hospital Medical Imaging, University of British Columbia, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    AJR Am J Roentgenol 193:W214-9. 2009
    ..The wide range of MDCT imaging findings that are critical for planning and performing TAVR will be reviewed...
  51. doi Role of echocardiography in percutaneous aortic valve implantation
    Robert R Moss
    Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
    JACC Cardiovasc Imaging 1:15-24. 2008
    ..This study was designed to investigate the usefulness and limitations of echocardiography in optimizing the outcome of percutaneous aortic valve implantation...
  52. ncbi Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial
    Christopher E Buller
    University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia, Canada
    Am Heart J 155:121-7. 2008
    ..We sought to describe the frequency of fibrinolytic failure (rescue eligibility) as well as the patient characteristics associated with rescue eligibility, rescue referral, and PCI...
  53. doi Transcatheter valve-in-valve aortic valve implantation: 16-month follow-up
    Jian Ye
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Ann Thorac Surg 88:1322-4. 2009
    ..Transcatheter transapical valve-in-valve aortic valve implantation is feasible and could be a viable approach for selected patients...
  54. ncbi Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients
    Jian Ye
    Divisions of Cardiac Surgery and Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    Eur J Cardiothorac Surg 31:16-21. 2007
    ..We now report 6-month follow-up in our initial seven patients...
  55. ncbi N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
    Stephen J Shalansky
    Pharmacy Department, St Paul s Hospital, and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Pharmacotherapy 25:1095-103. 2005
    ....
  56. ncbi Percutaneous closure of prosthetic paravalvular leaks: case series and review
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital and the University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 68:528-33. 2006
    ..Percutaneous transcatheter closure techniques, now routinely applied in the management of pathological cardiac and vascular communications, may be adaptable to PVL closure, potentially offer symptomatic relief...
  57. ncbi N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect
    Adeera Levin
    Division of Nephrology, Room 6010, Providence Health Care Saint Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver V6Z 1Y6, BC, Canada
    Nephrol Dial Transplant 22:2520-4. 2007
    ....
  58. pmc Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment
    Christopher E Buller
    University of British Columbia, Vancouver
    Can J Cardiol 22:511-5. 2006
    ..Few data exist describing the use of subcutaneous or intravenous enoxaparin as an anticoagulant in the highly thrombotic setting of primary percutaneous coronary intervention (PCI) for STEMI...
  59. ncbi Venture wire control catheter
    Samuel J McClure
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 66:346-50. 2005
    ..There were no device-related complications. Percutaneous coronary intervention was successful in all patients. Our initial experience with the Venture wire control catheter has been favorable...
  60. ncbi An unusual complication of coil embolization of a large coronary-pulmonary fistula
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
    J Invasive Cardiol 15:717-8. 2003
    ..This case highlights an unusual complication of fistula embolization and emphasizes the need for caution when occluding vessels which may supply the sinus node...
  61. ncbi Techniques for percutaneous closure of prosthetic paravalvular leaks
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 67:158-66. 2006
    ..Reports are few; success variable and techniques vary widely. We review the current considerations and techniques of percutaneous transcatheter closure of paravalvular leaks...
  62. ncbi Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital and Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 63:177-82; discussion 183. 2004
    ..The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis...
  63. doi Endovascular balloon occlusion for catheter-induced large artery perforation in the catheterization laboratory
    Jean Bernard Masson
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    Catheter Cardiovasc Interv 73:514-8. 2009
    ..Endovascular occlusion may provide rapid control of hemorrhage and facilitate definitive therapy; yet, occlusion balloons are not commonly utilized in the cardiac catheterization laboratory...
  64. ncbi Water for contrast-induced nephropathy? A thirst for knowledge
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Invasive Cardiol 15:703-5. 2003
  65. ncbi Repeated Günther Tulip inferior vena cava filter repositioning to prolong implantation time
    Kiang Hiong Tay
    Department of Radiology, University of British Columbia Hospitals, Campus Site, 2211 Wesbrook Mall, Vancouver, V6T 2B5 British Columbia, Canada
    J Vasc Interv Radiol 13:509-12. 2002
    ..In this way, the implantation time of the filter was extended beyond the recommended period of 10 days. The filter was successfully retrieved 19 days later during percutaneous closure of the PFO...
  66. ncbi Transapical aortic valve implantation in humans
    Jian Ye
    Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
    J Thorac Cardiovasc Surg 131:1194-6. 2006
  67. ncbi Percutaneous closure of a para-anastomotic abdominal aortic graft leak
    Abdulmajeed Alzubaidi
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
    Catheter Cardiovasc Interv 68:799-802. 2006
    ..Reoperation may be associated with significant morbidity and mortality. We report successful percutaneous transcatheter closure of an anastomotic graft leak utilizing an occluder device...
  68. ncbi Preventing subacute thrombosis
    Gordon Pate
    Interventional Cardiology and Cardiac Catheterization, St Paul s Hospital, Vancouver, British Columbia, Canada
    J Invasive Cardiol 14:369-70. 2002
  69. ncbi Heyde's syndrome: a review
    Gordon E Pate
    Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    J Heart Valve Dis 13:701-12. 2004
    ..In those patients deemed unfit for surgery in whom no bleeding point can be identified, recurrent blood transfusions may offer some symptomatic relief...
  70. ncbi Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Chest 132:1794-803. 2007
    ..In cardiogenic shock (CS), conclusive data on serial hemodynamic measurements for treatment guidance and prognosis are lacking...
  71. ncbi Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry
    Rupert Fincke
    New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
    J Am Coll Cardiol 44:340-8. 2004
    ..We sought to analyze clinical, angiographic, and outcome correlates of hemodynamic parameters in cardiogenic shock...
  72. ncbi Extensive thrombus of distal anastomosis of saphenous vein graft
    Javier Martín de la Torre
    Interventional Cardiology Department, San Carlos University Hospital, Plaza Cristo Rey s n planta 2N, 28040 Madrid, Spain
    J Invasive Cardiol 16:198-200. 2004
  73. ncbi Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial
    Timothy A Sanborn
    Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
    J Am Coll Cardiol 42:1373-9. 2003
    ....
  74. ncbi Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent r
    Vladimir Dzavik
    Interventional Cardiology Program, University Health Network, and University of Toronto, Toronto, Ontario, Canada
    Am Heart J 149:1128-34. 2005
    ..We sought to determine the reason for this finding by examining the baseline characteristics and outcomes of the 2 treatment groups by age...
  75. ncbi Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK)
    Harvey D White
    Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand
    Circulation 112:1992-2001. 2005
    ..The objective of this analysis was to compare the effects of PCI and CABG on 30-day and 1-year survival in the SHOCK trial...
  76. ncbi Transcatheter valve in valve implants for failed prosthetic valves
    John G Webb
    Catheter Cardiovasc Interv 70:765-6. 2007
  77. ncbi Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York City, NY, USA
    Am J Cardiol 100:1370-5. 2007
    ....
  78. ncbi Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study
    Vladimir Dzavik
    University Health Network, Toronto General Hospital, 6 246, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Eur Heart J 28:1109-16. 2007
    ..We assessed preliminary efficacy and safety of four doses of l-n-monomethyl-arginine (l-NMMA), a non-selective NOS inhibitor, in patients with AMI complicated by CS despite an open infarct-related artery...
  79. doi Percutaneous valve procedures: an update
    Laurens F Tops
    Curr Probl Cardiol 33:417-57. 2008
    ..In addition, an update on the ongoing trials in percutaneous valve procedures is presented. Finally, the role of imaging in performing percutaneous valve procedures will be discussed...
  80. doi Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry
    Marco De Carlo
    Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
    Catheter Cardiovasc Interv 72:196-203. 2008
    ..The aim of this study was to investigate the safety and efficacy of an innovative thrombectomy device, the Rinspiration System, which simultaneously "rinses" the vessel with turbulent flow and aspirates thrombus...
  81. ncbi Beating-heart percutaneous mitral valve repair using a transcatheter endovascular suturing device in an animal model
    Tasneem Z Naqvi
    Edwards Lifesciences, 1 Edwards Way, Irvine, CA 92614, USA
    Catheter Cardiovasc Interv 69:525-31. 2007
    ..Because of its simplicity, it has been applied in minimally invasive surgery, and recently, in the design of endovascular closed-heart devices...
  82. pmc The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents
    Machael P Love
    Division of Cardiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
    Can J Cardiol 23:121-3. 2007
    ..The purpose of the present statement is to summarize the available evidence relating to DES thrombosis and to provide practical recommendations regarding DES use and antiplatelet therapy...
  83. pmc Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York 10016, USA
    JAMA 295:2511-5. 2006
    ....
  84. ncbi An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction
    Michael E Farkouh
    Cardiovascular Institute, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, New York 10029, USA
    Clin Cardiol 29:204-10. 2006
    ..The role of diabetes mellitus (DM) in cardiogenic shock (CS) complicating an acute myocardial infarction (AMI) is not well understood. Previous studies have reported an in-hospital mortality rate for patients with DM and CS of about 60%...
  85. ncbi Stenting for coronary artery spasm
    Shailesh Khatri
    John Flynn Hospital, Gold Coast, Queensland, Australia
    Catheter Cardiovasc Interv 56:16-20. 2002
    ..In the rare, carefully selected patient, stents may represent an adjunct in the management of focal coronary artery spasm, although currently medical therapy remains the standard initial approach...
  86. ncbi Restrictive physiology in cardiogenic shock: observations from echocardiography
    Harmony R Reynolds
    Department of Medicine, New York University School of Medicine, New York, NY, USA
    Am Heart J 151:890.e9-15. 2006
    ..We hypothesized that restrictive physiology plays a role in cardiogenic shock (CS)...